Literature DB >> 6148705

Pattern of presynaptic nerve activity can determine the type of neurotransmitter regulating a postsynaptic event.

N Y Ip, R E Zigmond.   

Abstract

The mammalian superior cervical ganglion has been the classical preparation for studying cholinergic transmission between neurones. Recently, however, evidence has been presented showing that, in addition to the postsynaptic changes mediated via nicotinic and muscarinic receptors, there is a non-cholinergic component to transmission in this ganglion, as in frog paravertebral ganglia. In the rabbit superior cervical ganglion, Ashe and Libet recorded a late, slow excitatory postsynaptic potential in response to preganglionic nerve stimulation in the presence of nicotinic and muscarinic antagonists. We have found, in the rat superior cervical ganglion, that a postsynaptic biochemical consequence of preganglionic nerve stimulation, namely the acute activation of tyrosine 3-monooxygenase (tyrosine hydroxylase, TH; EC 1.14.16.2), is mediated in part by acetylcholine and in part by a non-cholinergic neurotransmitter. The regulation of this enzyme activity is of particular interest because it catalyses the rate-limiting step in the biosynthesis of the postganglionic neurotransmitter, noradrenaline. In the present paper, we report that the relative importance of cholinergic and non-cholinergic transmission in the regulation of TH activity varies with the pattern of electrical stimulation of the preganglionic nerve trunk.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148705     DOI: 10.1038/311472a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

1.  Temporal pattern dependence of neuronal peptide transmitter release: models and experiments.

Authors:  V Brezina; P J Church; K R Weiss
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  Control of time-dependent biological processes by temporally patterned input.

Authors:  V Brezina; I V Orekhova; K R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex.

Authors:  Z Y Tong; P G Overton; D Clark
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Profile of Nancy Ip.

Authors:  Jennifer Viegas
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

5.  The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion.

Authors:  T D Wakade; M A Blank; R K Malhotra; R Pourcho; A R Wakade
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

Review 6.  Autonomic control of adrenal function.

Authors:  A V Edwards; C T Jones
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

7.  Sodium dynamics underlying burst firing and putative mechanisms for the regulation of the firing pattern in midbrain dopamine neurons: a computational approach.

Authors:  C C Canavier
Journal:  J Comput Neurosci       Date:  1999-01       Impact factor: 1.621

8.  Effect of acute and chronic diisopropylfluorophosphate and atropine administration on somatostatin binding in the rat frontoparietal cortex and hippocampus.

Authors:  I A Alonso; J C Prieto; E Arilla
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  A pharmacological analysis of the burst events induced in midbrain dopaminergic neurons by electrical stimulation of the prefrontal cortex in the rat.

Authors:  P G Overton; Z Y Tong; D Clark
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 10.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.